A Safety And Efficacy Study Of ALG-1001 In Human Subjects With Wet Age-Related Macular Degeneration
Status:
Completed
Trial end date:
2013-06-07
Target enrollment:
Participant gender:
Summary
The general objective of this study is to evaluate the safety and efficacy of ophthalmic
intravitreal injections of ALG-1001 in human subjects with wet age-related macular
degeneration (Wet AMD). This study builds upon the safety and efficacy results of numerous
animal studies and an earlier Phase I Human Study in end-stage diabetic macular edema
patients.